Publicaciones en colaboración con investigadores/as de Hospital de Cruces (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  3. Impact of new technologies on neurology in Spain. Review by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology

    Neurologia, Vol. 38, Núm. 8, pp. 591-598

  4. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

2019

  1. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

2018

  1. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

    Journal of Huntington's Disease, Vol. 7, Núm. 3, pp. 209-222

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

2015

  1. Relationship between Nutritional Status and the Severity of Huntington's Disease. A Spanish Multicenter Dietary Intake Study

    Journal of Huntington's Disease, Vol. 4, Núm. 1, pp. 75-85

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218

2011

  1. Diminished thrombogenic responses by deletion of the Podocalyxin gene in mouse megakaryocytes

    PLoS ONE, Vol. 6, Núm. 10

  2. Release of podocalyxin into the extracellular space. Role of metalloproteinases

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1813, Núm. 8, pp. 1504-1510

2010

  1. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

    Clinical Genetics, Vol. 77, Núm. 1, pp. 60-69

  2. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families

    Cancer Research, Vol. 70, Núm. 19, pp. 7379-7391

  3. Ventricular enlargement associated with the panneural ablation of the podocalyxin gene

    Molecular and Cellular Neuroscience, Vol. 43, Núm. 1, pp. 90-97

2009

  1. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124